NJ Bio, Inc. is a premier CRO/CDMO specializing in antibody-drug conjugates (ADCs), antibody-oligonucleotide conjugates, and related bioconjugation chemistry. The company provides integrated chemistry services from discovery through GMP manufacturing, including custom synthesis of payloads, linkers, drug-linkers, and bioconjugation. NJ Bio has facilities in Princeton, New Jersey with specialized laboratories for high-potency API handling.
antibody-drug conjugate (ADC) development and GMP manufacturing, bioconjugation chemistry, linker-payload synthesis, high-potency API manufacturing, translational research
2 sites worldwide
No reviews available yet.
No documents available.